XML 26 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
3 Months Ended
May 02, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Stock Option Activity

 

 

 

Number of

shares

 

 

Weighted-average

exercise price

per option

 

 

Weighted-average

remaining

contractual term

 

 

Aggregate

intrinsic value

 

Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at beginning of year

 

 

754,833

 

 

$

4.84

 

 

3.1 years

 

 

$

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

Options expired and canceled

 

 

(216,548

)

 

$

4.86

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at end of quarter

 

 

538,285

 

 

$

4.83

 

 

3.1 years

 

 

$

 

Options exercisable at end of quarter

 

 

533,285

 

 

$

4.85

 

 

3.1 years

 

 

$

 

Employee Stock Plan, 2006 Plan, 2016 Plan and Inducement Awards  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Restricted Stock Activity

The following tables summarize the share activity and stock option activity for the Company’s 2006 Plan, 2016 Plan and inducement awards, on a combined basis, for the first three months of fiscal 2020:

 

 

RSUs (1)

 

 

Deferred shares (2)

 

 

Fully-vested

shares (3)

 

 

Performance Share Units (4)

 

 

Total number of shares

 

 

Weighted-average

grant-date

fair value

 

Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding non-vested shares at beginning of year

 

 

1,420,803

 

 

 

295,604

 

 

 

 

 

 

720,000

 

 

 

2,436,407

 

 

$

1.95

 

Shares granted

 

 

 

 

 

45,714

 

 

 

69,440

 

 

 

 

 

 

115,154

 

 

$

1.08

 

Shares vested/issued

 

 

(436,839

)

 

 

(6,245

)

 

 

(69,440

)

 

 

 

 

 

(512,524

)

 

$

2.20

 

Shares canceled

 

 

(17,443

)

 

 

 

 

 

 

 

 

 

 

 

(17,443

)

 

$

2.11

 

Outstanding non-vested shares at end of quarter

 

 

966,521

 

 

 

335,073

 

 

 

 

 

 

720,000

 

 

 

2,021,594

 

 

$

1.84

 

 

(1)

During the first three months of fiscal 2020, the vesting of RSUs was primarily related to the time-based awards under the Company’s LTIP plans, see Note 5, Long-Term Incentive Plans.

 

(2)

The 45,714 shares of deferred stock, with a grant date fair value of $49,371, represent compensation to certain directors in lieu of cash, in accordance with their irrevocable elections.  The shares of deferred stock will vest three years from the date of grant or at separation of service, based on the irrevocable election of each director.

 

(3)

During the first three months of fiscal 2020, the Company granted 69,440 shares of stock, with a fair value of approximately $74,995, to certain directors as compensation in lieu of cash, in accordance with their irrevocable elections. Directors are required to elect 50% of their quarterly retainer in equity.  Any shares in excess of the minimum required election are issued from the Company’s Fourth Amended and Restated Non-Employee Director Compensation Plan (“Non-Employee Director Compensation Plan”).

 

(4)

The 720,000 shares of performance stock units (“PSUs”), with a fair value of $1.0 million, represent a sign-on grant to Mr. Kanter.  The PSUs vest in installments when the following milestones are met: one-third of the PSUs vest when the trailing 90-day volume-weighted average closing stock price (“VWAP”) is $4.00, one-third of the PSUs vest when the VWAP is $6.00 and one-third when the VWAP is $8.00.  All PSUs will expire on April 1, 2023 if no performance metric is achieved.  The $1.0 million is being expensed over the respective derived service periods of each tranche of 16 months, 25 months and 30 months, respectively.  The respective fair value and derived service periods assigned to the PSUs were determined using a Monte Carlo model based on: the Company’s historical volatility of 55.9%, a term of 4.1 years, stock price on the date of grant of $2.50 per share, a risk-free rate of 2.5% and a cost of equity of 9.5%.